[Antihypertensive and noradrenaline-depleting effect of alpha methyl tyramine and alpha methyl octapamine in the rat].
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001923:Brain Chemistry; D002395:Catecholamines / Q000032:analysis; D006321:Heart / Q000032:analysis; D006977:Hypertension, Renal / Q000188:drug therapy; D008297:Male; D008745:Methylation; D009638:Norepinephrine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000627:therapeutic use; D051381:Rats; D014316:Tritium; D014439:Tyramine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
D000959:Antihypertensive Agents; D002395:Catecholamines; D014316:Tritium; D009638:Norepinephrine; D014439:Tyramine
Effets antihypertenseurs et noradrénalinodépléteurs de l'a-méthyl-tyramine et de l'a-méthyl-octopamine chez le rat.